tiprankstipranks
Inozyme Pharma (INZY)
NASDAQ:INZY
US Market

Inozyme Pharma (INZY) Balance Sheet

280 Followers

Inozyme Pharma Balance Sheet

Inozyme Pharma's total assets for Q4 2023 were $200.85M, a decrease of -2.36% from the previous quarter. INZY total liabilities were $60.37M for the fiscal quarter, a 32.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 200.85M$ 139.19M$ 123.54M$ 169.36M$ 47.94M
Total Liabilities
$ 60.37M$ 20.80M$ 14.27M$ 11.26M$ 81.16M
Total Equity Gross Minority
$ 140.48M$ 118.39M$ 109.27M$ 158.10M$ -33.22M
Total Capitalization
$ 230.93M$ 128.50M$ 109.27M$ 158.10M$ -33.22M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 1.29M-
Currency in USD

Inozyme Pharma Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis